Tumour suppressor genes (TSGs) inhibiting normal cellular growth are frequently silenced epigenetically in cancer 1 . DNA methylation is commonly associated with TSG silencing
Tumour suppressor genes (TSGs) inhibiting normal cellular growth are frequently silenced epigenetically in cancer 1 . DNA methylation is commonly associated with TSG silencing 1 , yet mutations in the DNA methylation initiation and recognition machinery in carcinogenesis are unknown 2 . An intriguing possible mechanism for gene regulation involves widespread non-coding RNAs such as microRNA, Piwi-interacting RNA and antisense RNAs [3] [4] [5] . Widespread sense-antisense transcripts have been systematically identified in mammalian cells 6 , and global transcriptome analysis shows that up to 70% of transcripts have antisense partners and that perturbation of antisense RNA can alter the expression of the sense gene 7 . For example, it has been shown that an antisense transcript not naturally occurring but induced by genetic mutation leads to gene silencing and DNA methylation, causing thalassaemia in a patient 8 . Here we show that many TSGs have nearby antisense RNAs, and we focus on the role of one RNA in silencing p15, a cyclin-dependent kinase inhibitor implicated in leukaemia. We found an inverse relation between p15 antisense (p15AS) and p15 sense expression in leukaemia. A p15AS expression construct induced p15 silencing in cis and in trans through heterochromatin formation but not DNA methylation; the silencing persisted after p15AS was turned off, although methylation and heterochromatin inhibitors reversed this process. The p15AS-induced silencing was Dicer-independent. Expression of exogenous p15AS in mouse embryonic stem cells caused p15 silencing and increased growth, through heterochromatin formation, as well as DNA methylation after differentiation of the embryonic stem cells. Thus, natural antisense RNA may be a trigger for heterochromatin formation and DNA methylation in TSG silencing in tumorigenesis.
To test the hypothesis that antisense RNA may trigger epigenetic silencing of mammalian genes, we first searched the UCSC Genome Browser for the existence of antisense transcripts of 21 well-known TSGs, identifying antisense transcripts for each TSG (Supplementary Table 1 ). For example, p15, a well-documented TSG in many tumours 9 , has several annotated antisense transcripts (Supplementary Table 1 ). We next established a nuclear sense-antisense transcript library from HeLa cells (Supplementary Fig. 1 ). After polymerase chain reaction (PCR) sequencing of 192 randomly chosen library clones, we identified 111 genes containing sense-antisense pairs with lengths between 100 and 200 base pairs (bp), including p15 and E-cadherin (Supplementary Table 2 ). Based on these results, we focused further experiments on p15 because it is frequently deleted or hypermethylated in a wide variety of tumours including leukaemia, melanomas, gliomas, lung cancers and bladder carcinomas 9 . Interestingly, up to 60% of leukaemias show epigenetic silencing and methylation of p15 10 , although the initiating events in this process are unknown.
To confirm the existence of a naturally occurring p15AS RNA, we performed PCR with reverse transcription (RT-PCR) with a strandspecific primer and identified p15AS transcripts in two leukaemia cell lines (Fig. 1a) . We then performed rapid amplification of 59/39 complementary DNA (cDNA) ends (RACE), which identified a 34.8-kilobase (kb) p15 antisense transcript ( Supplementary Fig. 2) . To uncover the possible mechanistic connection between endogenous p15AS transcripts and human disease, we examined both p15 and its antisense in acute lymphoblastic leukaemia and acute myeloid leukaemia leukocytes, because these two types of leukaemia are frequently accompanied by p15 epigenetic silencing. We found that 11 out of 16 patient samples (69%) showed relatively increased expression of p15AS and downregulated p15 expression (6/11 in acute myeloid leukaemia and 5/5 in acute lymphoblastic leukaemia). In contrast, 16 normal controls showed high expression of p15 but relatively low expression of the p15AS (Fig. 1b) . Additionally, the two acute myeloid leukaemia lines, which displayed high p15AS and low p15 expression (Fig. 1a) , also exhibited DNA hypermethylation and typical heterochromatic features for silencing in the p15 promoter region (Supplementary Table 3) .
As a result, we hypothesized that p15AS might play a mechanistic role in p15 silencing in tumour cells. To test this, we engineered three reporter constructs ( p15AS driven by a cytomegalovirus (CMV) promoter located between the p15 promoter and the GFP gene; (3) pP15-ASD contains a stop sequence downstream of the CMV promoter that prevents p15AS transcription. These constructs were transfected into HCT116 cells, selected and evaluated by fluorescence-activated cell sorting (FACS), which was also used to sort cells for further culture, after which we evaluated p15 promoter activity by monitoring GFP expression through a second FACS analysis. Both FACS scan results showed that cells stably transfected with pP15-AS have significantly decreased percentages of GFP-positive cells, and this was progressive over time (Fig. 2b, c) . Repeat transfections in HeLa cells yielded similar results ( Supplementary Figs 3 and 4) . Thus, the p15 antisense transcript appears to induce partner sense gene silencing and this effect is relatively stable. Real-time RT-PCR showed that the expressed p15AS transcript downregulated both exogenously ( Supplementary Fig. 5 ) and endogenously ( Supplementary Fig. 6 ), which was confirmed by western blotting ( Supplementary Fig. 7 ). This effect was specific to p15, as the endogenous p16 transcript level was unaffected ( Supplementary  Fig. 8 ). We repeated the transfections with new vectors in which four nucleotides were replaced by site-directed mutagenesis (pP159 and pP15AS9; Supplementary Fig. 9a , b), allowing us to distinguish exogenous from endogenous transcripts. The ratio of antisense to sense expression after transfection was about one-quarter the ratio in leukaemia compared with normal lymphocytes (Supplementary Table 4 ). Furthermore, the exogenous antisense transcript abrogated expression of the exogenous p15 and reduced the endogenous p15 by about two-thirds ( Supplementary Fig. 9c ). Thus, the antisense transcript showed a strong cis effect and weaker trans effect on expression, which we then confirmed by a new vector separating the sense and antisense genes on different vectors ( Supplementary Fig. 10 ).
To test the stability of silencing induced by the antisense transcript, we constructed a fourth vector pP15-AS-Tre which placed the p15AS under a Tet-inducible expression system (Fig. 2a) . When antisense expression was induced with tetracycline for 10 days in stably transfected T-Rex-HeLa cells, p15-GFP-expressing cells showed a significant decrease in p15 promoter activity. Interestingly, tetracycline withdrawal did not reactivate p15 promoter activity (Fig. 2d) , suggesting that antisense RNA may function in initiation of epigenetic silencing rather than maintenance of silencing. A loxP/Cre deletion experiment further confirmed that removal of the CMV promoter for the p15AS did not reactivate p15 promoter activity once silencing had been established ( Supplementary Fig. 11 ), further confirming that stable silencing of p15 by p15AS persisted after the p15AS expression was eliminated.
Next, we tested for a possible alteration in DNA methylation, because p15 silencing often accompanies frequent hypermethylation of its promoter in leukaemia 10 . However, bisulphite sequencing analysis failed to show any significant changes in DNA methylation in the p15 promoter ( Supplementary Fig. 12 ). To identify an alternative mechanism, we analysed histone modifications in the p15 promoter region by chromatin immunoprecipitation (ChIP), because it has been reported that short interfering RNAs can induce methylation of histone 3 lysine 9 (H3K9) and demethylation of histone 3 lysine 4 (H3K4) experimentally in human cells 11, 12 . Using the pP159 and pP15AS9 vectors ( Supplementary Fig. 9a, b) and sequence-specific probes, we were able to distinguish the exogenous sequences from the endogenous sequences through the analysis of immunoprecipitated DNA. The exogenous p15 promoter showed a marked increase in dimethylation of H3K9 and a decrease in dimethylation of H3K4 in cells with antisense transcripts; this effect was found in both the p15 promoter and exon 1 regions (Fig. 3a, b) , suggesting that the antisense RNA may trigger heterochromatin formation that leads to the transcriptional silencing of the sense p15. Interestingly, altered chromatin modifications affected not only the exogenous p15 promoter and exon 1 (Fig. 3a, b) , but also the endogenous p15 promoter (Fig. 3c, d) , although the magnitude of chromatin modification of the endogenous promoter was less than that of the exogenous promoter ( Fig. 3a-d) . Thus, the antisense RNA may have both a cis-and trans-acting function in heterochromatin formation. Furthermore, for the endogenous p15 promoter, a much larger region could be examined, which revealed that the decrease in H3K4 methylation was over a much smaller interval (about 1 kb) than the increase in H3K9 methylation (about 6 kb). Chromatin modifications were stable, because cells transfected with a tetracycline-inducible p15AS vector (Fig. 2a) showed reduced H3K4 methylation and increased expression induced an increase in H3K9 dimethylation and a decrease in H3K4 dimethylation in the exogenous p15 promoter region. ChIP enrichment was measured using real-time PCR, normalized by input DNA. The endogenous and exogenous genes were distinguished with probes specific for sense (pP159) and antisense (pP15-AS9) vectors transfected after modification by site-directed mutagenesis (see Supplementary Fig. 9 ). b, Antisense expression induced an increase in H3K9 dimethylation and a decrease in H3K4 dimethylation in the exogenous p15 exon 1 region. promoter. Significant differences were tested compared with pP15 (n 5 3). Error bars, s.d.; *P , 0.05; **P , 0.01; ***P , 0.001.
H3K9 methylation with p15 silencing. After tetracycline withdrawal, H3K4 methylation remained reduced at the same level, and H3K9 was somewhat reduced but still significantly elevated over control ( Supplementary Fig. 13 ). Recent reports show that both 5-aza-29-deoxycytidine and trichostatin A can relieve H3K9 methylation-induced repression 13, 14 . The treated cells were subsequently evaluated by FACS and showed that exposure to either 5-aza-29-deoxycytidine or trichostatin A could restore p15 promoter activity (Fig. 3e, and Supplementary Fig. 14) . Interestingly, the epigenetic silencing could not be reactivated by transforming-growth-factor-b, an activator of p15 15 (Supplementary Fig. 15) .
One mechanism for carcinogenesis is thought to involve the clonal expansion of cancer stem cells, and epigenetic modifications may arise early in such cells within individual tissues 16, 17 . Thus, we investigated the effect of p15AS expression in mouse embryonic stem cells. After selection of embryonic stem cells, FACS demonstrated results similar to those observed in HCT116 and HeLa cells (Fig. 4a) , which was confirmed by real-time RT-PCR ( Supplementary Fig. 16 ) and ChIP (Fig. 4b) . Furthermore, there was no change in promoter DNA methylation (Fig. 4c) , suggesting that heterochromatin rather than DNA methylation is a prerequisite for gene silencing. However, after differentiating embryonic stem cells for one week in vitro to form embryoid bodies, we were surprised to discover hypermethylation at the p15 promoter region (Fig. 4c) . Finally, when transfected mouse embryonic stem cells were cultured individually, we found that when stably transfected with pP15-AS they had significantly increased growth rates compared with pP15 control cells ( Supplementary  Figs 17 and 18) . These results provide functional confirmation that the p15AS transcript represses p15 sense expression.
Dicer is a central component of the short interfering RNA and microRNA silencing pathways 18 . To determine if it plays a role in epigenetic silencing of p15 induced by antisense RNA, we transfected the pP15-AS vector into murine Dicer knockout (Dicer (2/2) ) embryonic stem cells and selected, sorted and assayed these cells as described above. Surprisingly, it was found that the Dicer knockout did not affect antisense-induced silencing of p15 (Supplementary Fig.  19 ), indicating the mechanism of p15AS RNA-induced silencing was independent of Dicer.
In summary, the results of these experiments suggest that an antisense RNA may trigger transcriptional silencing of a partner sense tumour suppressor gene; this effect occurs both in cis and in trans, and is Dicer-independent. The biochemical mediators of this silencing remain to be determined, but might, for example, involve a Piwi-like protein, as their role in mammalian gene silencing is just beginning to be understood 19 . The silencing induced by the antisense transcript could occur through a 'hit and run' mechanism, because the effect persisted after the antisense transcription was eliminated by either a tetracycline-inducible vector or by loxP/Cre excision. This provides evidence for long-lasting heritable effects on gene expression caused by transient bursts in antisense gene expression, through heterochromatin formation, and that DNA methylation is a secondary effect occurring after differentiation of these cells. The evidence using embryonic stem cells provides a developmental context for this effect, which will need to be ultimately confirmed in tumour stem cells.
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These results have practical implications, in that activated antisense transcripts might be potential molecular markers for assessment of cancer risk, as well as serving as novel therapeutic or chemopreventative targets. These data are also consistent with the epigenetic progenitor hypothesis of cancer, which states that tumours arise from epigenetic alterations in progenitor cells that can differentiate into the mass population of cells observed clinically. An example is loss of imprinting in progenitor cells 17, 20 , and in the present case would be antisense silencing and heterochromatinization of a TSG.
METHODS SUMMARY
The vector Pires2-EGFP was used to construct pP15, pP15-AS and pP15-ASD. The Tet-inducible vector pcDNA4/TO/myc-His A was used to create pP15-ASTre, which was transfected into the T-REx-HeLa cell line. The transfection was done according to the manufacturer's instructions. FACS was applied to evaluate p15 promoter activity or sort GFP-positive cells. All transcriptional levels were measured by real-time RT-PCR with internal control. DNA methylation was analysed by bisulphite PCR pyrosequencing. H3K4 and H3K9 methylations were analysed by ChIP and real-time PCR. Mouse embryonic stem-cell differentiation was performed in the absence of leukaemia inhibitory factor (LIF) in bacterial Petri dishes to avoid cell adherence.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
